Capital Group Private Client Services, Inc. Seagen Inc. Transaction History

Capital Group Private Client Services, Inc.

$9.45 Billion
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $63.5 Million - $71.6 Million	-331,454 Reduced 84.87%	59,073 $12.5 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $54.8 Million - $60.3 Million	-292,132 Reduced 42.79%	390,527 $75.2 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $13.1 Million - $20.9 Million	-102,966 Reduced 13.11%	682,659 $138 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $2.11 Million - $2.5 Million	-17,985 Reduced 2.24%	785,625 $101 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $22,860 - $30,438	169 Added 0.02%	803,610 $110 Million

Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $2.31 Million - $3.81 Million	21,262 Added 2.72%	803,441 $142 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $18.1 Million - $23.9 Million	151,206 Added 23.96%	782,179 $113 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $15.3 Million - $20.5 Million	-107,500 Reduced 14.56%	630,973 $97.5 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $105 Million - $125 Million	738,473 New	738,473 $125 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Account